首页> 外文OA文献 >Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells

【2h】

Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells

机译：药理学上调的癌丙烯抗原表达增强了遗传修饰的嵌合抗原受体NK-92MI对结直肠癌细胞的细胞溶解活性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Masayuki Shiozawa; Chuan-Hsin Chang; Yi-Chun Huang; Yi-Ching Chen; Mau-Shin Chi; Hsu-Chao Hao; Yue-Cune Chang; Satoru Takeda; Kwan-Hwa Chi; Yu-Shan Wang;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 在体内和体外条件下阿奇霉素通过抑制自噬和上调结肠癌细胞内DR4/5蛋白水平增强TRAIL抗癌活性 [J] . Xinran Qiao, Xiaofei Wang, Yue Shang, 癌症（英文版） . 2018,第012期
2. Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells [J] . Masayuki Shiozawa, Chuan-Hsin Chang, Yi-Chun Huang, BMC Immunology . 2018,第1期

机译：药理学上调的癌胚抗原表达增强了基因修饰的嵌合抗原受体NK-92MI对结直肠癌细胞的溶细胞活性
3. Antitumor activity of chimeric immunoreceptor gene-modified Tc1 and Th1 cells against autologous carcinoembryonic antigen-expressing colon cancer cells. [J] . Sasaki T, Ikeda H, Sato M, Cancer science. . 2006,第9期

机译：嵌合免疫受体基因修饰的Tc1和Th1细胞对自体表达癌胚抗原的结肠癌细胞的抗肿瘤活性。
4. Engraftment of mesothelin chimeric antigen receptor using a hybrid Sleeping Beauty/minicircle vector into NK-92MI cells for treatment of pancreatic cancer [J] . Batchu Ramesh B., Gruzdyn Oksana V., Tavva Pavan S., Surgery . 2019,第4期

机译：植物素嵌合抗原受体使用杂交睡眠美容/小型循环载体进入NK-92MI细胞以治疗胰腺癌
5. Main Issues and Current Strategies in Enhancing the Efficacy of Chimeric Antigen Receptor T-Cell Therapy among Tumor Treatments [C] . Zhengting He International Conference on Frontiers of Biological Sciences and Engineering . 2020

机译：提高嵌合抗原受体T细胞治疗肿瘤治疗疗效的主要问题及目前策略
6. Carcinoembryonic antigen (CEA) inhibits anoikis in colorectal cancer (CRC) cells by interfering with TRAIL-R2 (DR5) signaling [D] . Samara, Raed N. 2006

机译：癌胚抗原（CEA）通过干扰TRAIL-R2（DR5）信号传导来抑制结直肠癌（CRC）细胞的失神经
7. Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells [O] . Masayuki Shiozawa, Chuan-Hsin Chang, Yi-Chun Huang, 2018

机译：药理学上调的癌胚抗原表达增强了基因修饰的嵌合抗原受体NK-92MI对结直肠癌细胞的溶细胞活性
8. Antitumor activity of chimeric immunoreceptor gene-modified Tc1 and Th1 cells against autologous carcinoembryonic antigen-expressing colon cancer cells [O] . Takeshi Sasaki, Hiroaki Ikeda, Masayoshi Sato, 2006

机译：嵌合免疫受体基因改性TC1和Th1细胞对抗自体癌丙烯抗原的结肠癌细胞的抗肿瘤活性

Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells

著录项

引文网络

相似文献

相关主题

期刊订阅